Comparison of FOLFIRI with or without cetuximab in patients with resected stage III colon cancer; NCCTG (Alliance) intergroup trial N0147.

Huang J, Nair SG, Mahoney MR, Nelson GD, Shields AF, Chan E, Goldberg RM, Gill S, Kahlenberg MS, Quesenberry JT, Thibodeau SN, Smyrk TC, Grothey A, Sinicrope FA, Webb TA, Farr GH, Pockaj BA, Berenberg JL, Mooney M, Sargent DJ, Alberts SR, Alliance for Clinical Trials in Oncology
Clin Colorectal Cancer. 2014 13 (2): 100-9

PMID: 24512953 · PMCID: PMC4019685 · DOI:10.1016/j.clcc.2013.12.002

MeSH Terms (24)

Adult Aged Aged, 80 and over Antibodies, Monoclonal, Humanized Antineoplastic Combined Chemotherapy Protocols Camptothecin Cetuximab Chemotherapy, Adjuvant Colonic Neoplasms Disease-Free Survival Female Fluorouracil Follow-Up Studies Humans Leucovorin Male Middle Aged Mutation Neoplasm Staging Proto-Oncogene Proteins Proto-Oncogene Proteins p21(ras) ras Proteins Survival Rate Treatment Outcome

Connections (1)

This publication is referenced by other Labnodes entities: